US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

Share of pharma companies saw red on February 14 as caution over the possibility of US tariffs hitting the sector spread across the Street. This came after US President Donald Trump told reporters Thursday he would also levy tariffs on foreign cars, semiconductors and pharmaceuticals in addition to his plans of imposing reciprocal tariffs.

Caught amidst tariff concerns shares of India’s prominent drugmakers–Dr Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma–slipped 1-4 percent. These companies have a relatively high exposure to the US drug market and higher tariffs on imports threaten to squeeze their margin and eat away pricing competitiveness.

Other drugmakers like Granules India, Natco Pharma, Laurus Labs, Glenmark, Mankind Pharma, Biocon and Divi’s Labs also shed 2-9 percent, weighing on the broader pharma index. As a result, the Nifty Pharma index tanked around 3 percent to emerge as the worst performing sector in trade today.

NIFTY Pharma Top Stock Losers (Intra-day)

COMPANY CMP CHG(%) VOLUME
Laurus Labs 547.30 -8.94 6.34m
Natco Pharma 891.85 -8.53 7.55m
Granules India 511.65 -5.64 1.15m
Glenmark 1,333.05 -5.54 1.31m
Lupin 1,964.05 -4.44 1.25m
Zydus Life 904.15 -4.1 887.10k
Mankind Pharma 2,399.60 -4.06 754.11k
Aurobindo Pharm 1,136.40 -3.69 1.09m
Biocon 349.55 -2.71 2.56m
Divis Labs 5,852.00 -2.64 239.62k
Sun Pharma 1,705.05 -2.36 1.46m
Dr Reddys Labs 1,197.25 -2.15 907.44k
Torrent Pharma 3,020.35 -1.75 264.44k
Alkem Lab 4,649.85 -1.48 194.61k
Ipca Labs 1,470.00 -1.4 1.11m
Abbott India 27,970.40 -1.37 8.39k
Gland 1,463.00 -0.89 60.41k
Cipla 1,460.10 -0.82 1.33m
JB Chemicals 1,679.50 -0.25 103.22k

If Trump were to impose tariffs on pharmaceutical imports to the US, it could deal a significant blow to Indian drugmakers. The added costs would make exporting drugs to the US more expensive, potentially squeezing profit margins for major Indian pharmaceutical companies like Sun Pharma, Dr Reddy’s, and Cipla, all of which have substantial exposure in the US generics market.

Additionally, such tariffs could weaken the competitive edge of Indian drugmakers in the US. These companies rely on cost efficiency to compete with domestic US manufacturers, but higher tariffs could drive up prices, making Indian medicines less attractive and diminishing their market share.

Aside from tariff concerns, a slew of weak quarterly earnings from names like Natco Pharma, Granules India, Biocon and others, have also dampened sentiment for the sector.

Last month, Trump also froze foreign aid funding for HIV medicines to Africa, giving another blow to Indian drugmakers supplying antiretroviral (ARV) medications.

Related Posts

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

World’s 1st Dual Console Complex Robotic Beating Heart TECAB performed in India’   New Delhi: SSiMantra, the only ‘Made in India’ best in class surgical robot is as usual always…

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Three teams inspected several wholesale medicine shops following complaints of sales without bills, storage irregularities and alleged illegal trading of government-supplied medicines. Patna: The Drug Department has launched an inspection…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested